Figure 3From: Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancersThe 10-year relapse-free survival of 215 patients from Buffa et al.[23], stratified by RAD21 gene expression. (A) Cut-off at 66th percentile (that is, top third), and (B) cut-off at 50th percentile (that is, top half).Back to article page